NCT00229593View on ClinicalTrials.gov

NES Gel-1, To Evaluate Nestorone Gel in Combination With Testosterone Gel

PHASE1CompletedINTERVENTIONAL
Enrollment

140

Participants

Timeline

Start Date

September 30, 2005

Primary Completion Date

January 31, 2007

Study Completion Date

January 31, 2007

Conditions
Contraception
Interventions
DRUG

Nestorone gel

2 to 8 mg Nestorone gel daily for 3 weeks depending on treatment group assignment

DRUG

Testosterone Gel

100 mg Testosterone gel daily for 3 weeks

Trial Locations (2)

90509

Harbor-UCLA Medical Center, Torrance

98195

University of Washington Medical Center, Seattle

All Listed Sponsors
collaborator

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

NIH

lead

University of Washington

OTHER

NCT00229593 - NES Gel-1, To Evaluate Nestorone Gel in Combination With Testosterone Gel | Biotech Hunter | Biotech Hunter